Victory Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,499
Closed -$67K 2536
2025
Q1
$67K Buy
+15,499
New +$62.6K ﹤0.01% 2345
2024
Q3
Sell
-10,053
Closed -$28.1K 2513
2024
Q2
$28.1K Sell
10,053
-146
-1% -$392 ﹤0.01% 2405
2024
Q1
$29K Sell
10,199
-422
-4% -$1.43K ﹤0.01% 2423
2023
Q4
$43.4K Buy
+10,621
New +$29.7K ﹤0.01% 2450
2023
Q2
Sell
-28,343
Closed -$60.4K 2573
2023
Q1
$60.4K Sell
28,343
-2,556
-8% -$6.32K ﹤0.01% 2425
2022
Q4
$83.1K Sell
30,899
-125,772
-80% -$367K ﹤0.01% 2387
2022
Q3
$508K Sell
156,671
-5,063
-3% -$22.9K ﹤0.01% 2045
2022
Q2
$789K Sell
161,734
-70,867
-30% -$436K ﹤0.01% 1854
2022
Q1
$1.69M Buy
232,601
+3,895
+2% +$30.1K ﹤0.01% 1564
2021
Q4
$2.11M Buy
228,706
+176,616
+339% +$1.88M ﹤0.01% 1532
2021
Q3
$742K Buy
52,090
+24,584
+89% +$382K ﹤0.01% 1982
2021
Q2
$457K Buy
+27,506
New +$513K ﹤0.01% 2245
2020
Q2
Sell
-6,740
Closed -$22K 3035
2020
Q1
$22K Buy
+6,740
New +$28.9K ﹤0.01% 3062
2019
Q4
Sell
-1,148
Closed -$8K 3066
2019
Q3
$8K Buy
+1,148
New +$6.39K ﹤0.01% 3336

Other funds holding ORGO

Victory Capital Management's ORGO Position: Q2 2025 in Review

Victory Capital Management sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 15,499 shares — an estimated $67K sold.

Victory Capital Management first reported a position in ORGO in Q3 2019 and held it in 14 quarters. The position peaked at $2.11M in Q4 2021. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Victory Capital Management reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Victory Capital Management sold 15,499 Organogenesis Holdings shares in Q2 2025, an estimated $67K.
  • Victory Capital Management first reported a position in Organogenesis Holdings in Q3 2019 and held it in 14 quarters.
  • Victory Capital Management's Organogenesis Holdings position peaked at $2.11M in Q4 2021.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Victory Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.